Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.6.2491

MTHFR C667T Polymorphism Association with Lung Cancer Risk in Henan Province: A Case-control Study  

Cheng, Zhe (Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medical Research of Henan Universities)
Wang, Wei (Department of Occupational Health and Toxicology, School of Public Health, Zhengzhou University)
Dai, Ling-Ling (Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medical Research of Henan Universities)
Kang, Yan (Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medical Research of Henan Universities)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.6, 2012 , pp. 2491-2494 More about this Journal
Abstract
The current study was performed to assess any association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and risk of lung cancer in Henan province. This case-control study involved94 patients with newly histological confirmed lung cancer and 78 healthy controls. Genotyping was achieved with peripheral blood lymphocytes DNA and association of the polymorphism with risk of lung cancer was estimated by unconditional logistic regression analysis. The frequencies of the MTHFR 667TT genotype were 37.2% in cases compared with 23.1% in controls (${\chi}^2$ = 4.008, P = 0.045). Individuals with the 667CC/CT genotype displayed a significantly reduced risk of lung cancer compared with those with the TT genotypes [adjusted odds ratio (OR), 0.506; 95% confidence interval (95% CI), 0.258 - 0.991]. The C667T polymorphism might have a significant effect on the occurrence of lung cancer in Henan province.
Keywords
MTHFR; mononucleotide polymorphism; lung cancer; susceptibility;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Amos CI, Wu XF, Broderick P, et al (2008). Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genetics, 40, 616-22.   DOI
2 Arslan S, Karadayi S, Yildirim ME, Ozdemir O, Akkurt I (2011). The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep, 38, 991-6.   DOI
3 Boccia S, Boffetta P, Brennan P, et al (2009). Meta-analyses of the methylenete trahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett, 273, 55-61.   DOI   ScienceOn
4 Botto LD, Yang Q (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol, 151, 862-77.   DOI
5 Cui LH, Shin MH, Kim HN, et al (2011). Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med Genet, 22, 12-28.
6 Dong LM, Potter JD, White E, et al (2008). Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA, 299, 2423-36.   DOI   ScienceOn
7 Eaton AM, Sandler R, Carethers JM, et al (2005). 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev, 14, 2023-9.   DOI
8 Friso S, Choi SW (2005). Gene-nutrient interactions in onecarbon metabolism. Curr Drug Metab, 6, 37-46.   DOI   ScienceOn
9 Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature genetics, 10, 111-3.   DOI   ScienceOn
10 Gill P (2001). An assessment of the utility of single nucleotide polymorphisms (SNPs) for forensic purposes. Int J Legal Med, 114, 204-10.   DOI
11 Guenther BD, Sheppard CA, Tran P, et al (1999). The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol, 6, 359-65.   DOI
12 Hoekstra HE, Hirschmann RJ, Bundey RA, Insel PA, Crossland JP (2006). A single amino acid mutation contributes to adaptive beach mouse color pattern. Science, 313, 101-4.   DOI
13 Hung RJ, Hashibe M, McKay J, et al (2007). Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis, 28, 1334-40.   DOI   ScienceOn
14 Li D, Ahmed M, Li Y, Jiao L, et al (2005). 5, 10 - Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 14, 1470-6.   DOI
15 Jemal A, Siegel R, Xu J, Ward F (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.   DOI
16 Jin C, Zhang YH, Peng MF, et al (2007). Research of relationship between gene polymorphisms of methylenetetrahydrofolate reductase enzyme and lung cancer. Chin J Cancer Prevention and Treatment, 14, 888-91.
17 Jeng YL, Wu MH, Huang HB, et al (2003). The methylenetetrahydrofolate reductase 677C-->T polymorphism and lung cancer risk in a Chinese population. Anticancer Res, 23, 5149-52.
18 Li D, Pickell L, Liu Y, et al (2005). Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr, 82, 188-95.
19 Lin J, Spitz MR, Wang Y, et al (2004). Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a casecontrol study. Carcinogenesis, 25, 1639-47.   DOI
20 Liu CS, Tsai CW, Hsia TC, et al (2009). Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics, 6, 325-9.
21 Mao R, Fan Y, Jin Y, Bai J, Fu S (2008). Methy-lenetetrahydrofolate reductase gene polymorphisms and lung cancer: a metaanalysis. J Hum Genet, 53, 340-8.   DOI
22 Matsuo K, Suzuki R, Hamajima N, et al (2001). Association between polymorphisms of folate- and methioninemetabolizing enzymes and susceptibility to malignant lymphoma. Blood, 97, 3205-9.   DOI   ScienceOn
23 Shields PG (2002). Molecular epidemiology of smoking and lung cancer. Oncogene, 21, 6870-6.   DOI
24 Pepe G, Camacho Vanegas O, et al (1998). Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet, 63, 917-20.   DOI   ScienceOn
25 Poehlmann A, Kuester D, Meyer F, et al (2007). K-ras mutation detection in colorectal cancer using the Pyrosequencing technique. Pathol Res Pract, 203, 489-97.   DOI
26 Shen M, Rothman N, Berndt SI, et al (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer, 49, 299-309.   DOI   ScienceOn
27 Shi Q, Zhang Z, Li G, et al (2005). Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev, 14, 1477-84.   DOI   ScienceOn
28 Siemianowicz K, Gminski J, Garczorz W, et al (2003). Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and nonsmall cell lung cancer. Oncol Rep, 10, 1341-4.
29 Suzuki T, Matsuo K, Hiraki A, et al (2007). Impact of onecarbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis, 28, 1718-25.   DOI
30 Yu JM, Wang XC, Chen BB, et al (1998). The Various of Methylenetetrahydrofolate reductase gene polymorphism in five Chinese ethnic. Human Science, 17, 242-6.